Every disease has its myths and misconceptions about them. Prostate cancer is no different. The confusion surrounding the disease is often fueled by bad advice from well-meaning friends and the fact that many men often avoid talking about their condition. Few men sit around discussing prostate cancer and if it is brought up, after a few wisecracks are made the topic is usually abruptly changed.
Read MoreDr. David Samadi gives his expert opinion on the US Preventative Services Task Force 2017 Draft Recommendation Statement on screening for prostate cancer based on an updated systematic evidence review and assessment.
Read MoreA new, promising treatment for advanced prostate cancer is being tested, and it hails from a very unlikely source: the liver of a human fetus.
Read MoreWe are a nation of anxious people. Ten percent of Americans take antidepressants, and more than 60 percent of those people have taken them for 2 years or longer. Usually stats like these are a cause for hand-wringing, but new information about how antidepressants may work against prostate cancer may be putting a new spin on everything.
Read MoreFun fact: Dogs can smell prostate cancer. A 2014 study showed that trained canines can detect prostate cancer with greater than 97 percent accuracy.
Read MoreFor men under the age of 65, a good night's sleep may have just been promoted from a “nice to have” to a “need to have.” Investigators believe they have found a link between disrupted circadian rhythms and a greater risk of prostate cancer.
Read MoreGood news men – in case you didn’t know already know, orgasms not only feel fantastic but are also linked to a decreased risk of prostate cancer. It appears that men who ejaculate a lot over the course of a month are less likely to be diagnosed with prostate cancer.
Read MoreIf you are a man with prostate cancer, you have higher than normal levels of a protein known as AMACR. What's more, that protein has been linked to the aggressiveness of the cancer, and if your levels of AMACR can be lowered, the growth of your prostate cancer will also slow down commensurately.
Read MoreWhen you study about prostate cancer treatment you read an awful lotabout androgen deprivation therapy, radiation therapy and chemotherapy – because they work. You hear less about immunotherapy for prostate cancer because, despite its effectiveness against many cancers and other diseases, prostate cancer has been notoriously resistant to it.
Read MoreProstatic intraepithelial neoplasia or PIN is a condition in which cells from the prostate begin to look and behave abnormally. Each year around 16% of men who undergo a prostate biopsy will find out they have PIN which is essentially a precancerous condition and therefore is not prostate cancer.
Read MoreAlong with receiving a diagnosis of prostate cancer, comes new medical terminology that is likely unfamiliar to most men. One of the terms a man will hear is what is called a Gleason score. In 1966, a grading system for prostate cancer was developed by Dr. Donald Gleason. The Gleason score, still bearing his name today, is a system used to grade the aggressiveness of prostate cancer tissue.
Read MoreProstate cancer feeds on androgens – male hormones, like testosterone. A common tactic in the battle against prostate cancer is to deprive the cancer of the androgens it craves via androgen deprivation therapy. It won't kill the cancer, but it can slow it down, and against prostate cancer which usually moves glacially anyway, slowing it even more is often enough to checkmate it.
Read More
